<DOC>
	<DOCNO>NCT00416728</DOCNO>
	<brief_summary>This study assess bioavailability aliskiren valsartan single tablet compare dos two drug give two separate tablet healthy subject .</brief_summary>
	<brief_title>Bioavailability Aliskiren Valsartan Single Tablet vs. Same Doses Two Drugs Given Separately Healthy Subjects .</brief_title>
	<detailed_description />
	<mesh_term>Valsartan</mesh_term>
	<criteria>Healthy subject 18 45 year ( inclusive ) age good health determine past medical history , physical examination , vital sign assessment , electrocardiogram , laboratory test screen baseline.. Female subject child bear potential must use doublebarrier local contraception i.e . intrauterine device plus condom , spermicidal gel plus condom least 3 month prior Study start postmenopausal female must regular menstrual bleeding least 1 year prior inclusion ( Menopause confirm plasma FSH level &gt; 40 IU/L ) female subject must surgically sterilize least 6 month prior screen supportive clinical documentation . female subject must negative pregnancy result screen baseline ( regardless report reproductive status ) . Body mass index ( BMI ) must 18 – 30 kg/m2 ( inclusive ) subject must weigh least 50 kg . Vital sign within follow range : oral body temperature 35.037.5 °C , systolic blood pressure , 90140 mm Hg , diastolic blood pressure , 5090 mm Hg , pulse rate , 40 90 beat per minute ( bpm ) Smokers ( use tobacco product within previous 3 month ) . Smokers define report tobacco use urine cotinine value ≥ 300 ng/mL . Use prescription drug within 4 week prior dose , overthecounter ( OTC ) medication ( vitamin , herbal supplement , dietary supplement ) within 2 week prior dose . Acetominophen acceptable , supportive clinical documentation.. Participation clinical investigation within minimum 4 week prior dose ( longer local regulation apply ) . Significant illness within 2 week prior dose . Lactating breast feeding female . Other protocoldefined inclusion/exclusion criterion may apply</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>June 2007</verification_date>
	<keyword>Aliskiren , Valsartan , bioavailability , hypertension</keyword>
	<keyword>Healthy male female subject</keyword>
</DOC>